Robeauté Company Market Research Report
Company Overview
Name and Mission
- Name: Robeauté
- Mission: Robeauté is dedicated to developing innovative microrobots aimed at novel therapies for neurosurgical interventions, providing solutions for hard-to-reach areas of the body. Their microrobots are designed to improve surgical precision, enable localized therapy delivery, and facilitate anatomically precise data collection, eventually changing the landscape of medical treatments and research.
Founding Details
- Founded: 2017
- Founders:
- Bertrand Duplat - Founder & CEO with a background in robotics and 3D with 30+ years of experience and two successful exits.
- Joana Cartocci - Founder & COO with 10+ years in operational management and experience in multidisciplinary projects.
Key People
- Bertrand Duplat - CEO
- Joana Cartocci - COO
- Arthur André - Referent Neurosurgeon
- Quentin François - VP Product
- Ali Oulmas - VP Research
Headquarters
- Location: Paris, Île-de-France
Number of Employees
- Employees: 11-50
Revenue
- Information not available.
Known For
- Robeauté is primarily known for developing neurosurgical microrobots capable of high precision, 3D movements, and live data collection, integrating technologies across robotics, AI, and medicine to create advanced neurosurgical tools.
Products
Overview
Robeauté is developing a range of microrobots specifically engineered for use in neurosurgical procedures with applications extending to other complex bodily regions.
High-Level Product Descriptions
- Therapeutic Microrobots:
- These tiny microrobots are designed for hard-to-reach areas of the body to perform precise surgical interventions, biopsies, and localized data collection. They mark a shift from traditional robotic to microrobotic surgery, emphasizing enhanced precision and localized drug delivery.
Key Features
- Adaptability: They feature a modular design with a standard carrier and multiple extensions for various medical indications.
- Precision: Enabled by 3D, non-linear movements for intricate surgical procedures.
- Live-Data Collection: Equipped with sensors for real-time data collection.
- Minimal Invasiveness: Designed to navigate sensitive areas like the brain with minimal intrusion.
Recent Developments
Recent Initiatives
- Robeauté was selected for the MedTech Innovator’s 2024 cohort, positioning itself among the top 5% of medical technology startups selected from an initial pool of 1300 companies. This follows recognition at events such as the Hello Tomorrow Global Challenge and WIRED Health.
New Products
- Information not available.
New Features
- Ultrasound Tracking System: Developed for precise real-time localization of neurosurgical microrobots, enhancing operational accuracy and reducing invasiveness during procedures.
Partnerships
- Collaborates with medical centers and university labs across Europe and the United States as part of its R&D and product development strategy.
> This report is derived and constructed based on the specific data provided. All rights reserved to Robeauté.
